STAAR Surgical Company
STAA · NASDAQ
11/5/2025 | 9/26/2025 | 6/27/2025 | 3/28/2025 | |
|---|---|---|---|---|
| Revenue | – | $95 | $44 | $43 |
| % Growth | – | 113.7% | 4.1% | – |
| Cost of Goods Sold | – | $17 | $12 | $15 |
| Gross Profit | – | $78 | $33 | $28 |
| % Margin | – | 82.2% | 74% | 65.8% |
| R&D Expenses | – | $9 | $10 | $14 |
| G&A Expenses | – | $21 | $21 | $24 |
| SG&A Expenses | – | $44 | $47 | $49 |
| Sales & Mktg Exp. | – | $23 | $26 | $25 |
| Other Operating Expenses | – | $6 | $5 | $23 |
| Operating Expenses | – | $59 | $63 | $85 |
| Operating Income | – | $18 | -$30 | -$57 |
| % Margin | – | 19.5% | -67.6% | -134.8% |
| Other Income/Exp. Net | – | $0 | $4 | $3 |
| Pre-Tax Income | – | $19 | -$26 | -$54 |
| Tax Expense | – | $10 | -$9 | -$0 |
| Net Income | – | $9 | -$17 | -$54 |
| % Margin | – | 9.4% | -37.9% | -127.3% |
| EPS | – | 0.18 | -0.34 | -1.1 |
| % Growth | – | 152.9% | 69.1% | – |
| EPS Diluted | – | 0.18 | -0.34 | -1.1 |
| Weighted Avg Shares Out | – | 50 | 50 | 49 |
| Weighted Avg Shares Out Dil | – | 50 | 50 | 49 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $1 | $1 | $1 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $2 | $2 | $2 |
| EBITDA | – | $26 | -$23 | -$32 |
| % Margin | – | 27.9% | -51.3% | -76.1% |